APO Research
Talk to an analyst

APO RESEARCH · REPORT

China PD-L1 and PIK3CA Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global China PD-L1 and PIK3CA Testing Market Analysis and Forecast 2026-2032

29 December 2025195 pages

Choose your research edition.

Industry ResearchChina PD-L1 and PIK3CA Testing Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal China PD-L1 and PIK3CA Testing Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal China PD-L1 and PIK3CA Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal China PD-L1 and PIK3CA Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal China PD-L1 and PIK3CA Testing Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global China PD-L1 and PIK3CA Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for China PD-L1 and PIK3CA Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of China PD-L1 and PIK3CA Testing include Agilent Technologies, EntroGen, QIAGEN, Amoy Diagnostics, Roche and ACCB Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for China PD-L1 and PIK3CA Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of China PD-L1 and PIK3CA Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for China PD-L1 and PIK3CA Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the China PD-L1 and PIK3CA Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global China PD-L1 and PIK3CA Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for China PD-L1 and PIK3CA Testing revenue, projected growth trends, production technology, application and end-user industry.

China PD-L1 and PIK3CA Testing Segment by Company

Agilent Technologies

EntroGen

QIAGEN

Amoy Diagnostics

Roche

ACCB Biotech

China PD-L1 and PIK3CA Testing Segment by Type

PD-L1 Testing

PIK3CA Testing

China PD-L1 and PIK3CA Testing Segment by Application

Hospital

Diagnostic Center

Others

China PD-L1 and PIK3CA Testing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global China PD-L1 and PIK3CA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of China PD-L1 and PIK3CA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of China PD-L1 and PIK3CA Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of China PD-L1 and PIK3CA Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of China PD-L1 and PIK3CA Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, China PD-L1 and PIK3CA Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global China PD-L1 and PIK3CA Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PD-L1 Testing Major Player Table 3. PIK3CA Testing Major Player Table 4. Global China PD-L1 and PIK3CA Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Diagnostic Center Major Player Table 7. Others Major Player Table 8. China PD-L1 and PIK3CA Testing Industry Trends Table 9. China PD-L1 and PIK3CA Testing Industry Drivers Table 10. China PD-L1 and PIK3CA Testing Industry Opportunities and Challenges Table 11. China PD-L1 and PIK3CA Testing Industry Restraints Table 12. Global China PD-L1 and PIK3CA Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global China PD-L1 and PIK3CA Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global China PD-L1 and PIK3CA Testing Market Share by Region (2021-2026) Table 15. Global China PD-L1 and PIK3CA Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global China PD-L1 and PIK3CA Testing Market Share by Region (2027-2032) Table 17. Global China PD-L1 and PIK3CA Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Players (2021-2026) Table 19. Global China PD-L1 and PIK3CA Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global China PD-L1 and PIK3CA Testing Key Players Headquarters & Area Served Table 21. Global China PD-L1 and PIK3CA Testing Players, Product Type & Application Table 22. Global China PD-L1 and PIK3CA Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global China PD-L1 and PIK3CA Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global China PD-L1 and PIK3CA Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Type (2021-2026) Table 29. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Type (2027-2032) Table 30. Global China PD-L1 and PIK3CA Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Application (2021-2026) Table 34. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Application (2027-2032) Table 35. Agilent Technologies Company Information Table 36. Agilent Technologies Business Overview Table 37. Agilent Technologies China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Agilent Technologies China PD-L1 and PIK3CA Testing Product Portfolio Table 39. Agilent Technologies Recent Development Table 40. EntroGen Company Information Table 41. EntroGen Business Overview Table 42. EntroGen China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. EntroGen China PD-L1 and PIK3CA Testing Product Portfolio Table 44. EntroGen Recent Development Table 45. QIAGEN Company Information Table 46. QIAGEN Business Overview Table 47. QIAGEN China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. QIAGEN China PD-L1 and PIK3CA Testing Product Portfolio Table 49. QIAGEN Recent Development Table 50. Amoy Diagnostics Company Information Table 51. Amoy Diagnostics Business Overview Table 52. Amoy Diagnostics China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Amoy Diagnostics China PD-L1 and PIK3CA Testing Product Portfolio Table 54. Amoy Diagnostics Recent Development Table 55. Roche Company Information Table 56. Roche Business Overview Table 57. Roche China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Roche China PD-L1 and PIK3CA Testing Product Portfolio Table 59. Roche Recent Development Table 60. ACCB Biotech Company Information Table 61. ACCB Biotech Business Overview Table 62. ACCB Biotech China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ACCB Biotech China PD-L1 and PIK3CA Testing Product Portfolio Table 64. ACCB Biotech Recent Development Table 65. North America China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026) & (US$ Million) Table 66. North America China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032) & (US$ Million) Table 67. North America China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026) & (US$ Million) Table 68. North America China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032) & (US$ Million) Table 69. North America China PD-L1 and PIK3CA Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 70. North America China PD-L1 and PIK3CA Testing Revenue by Country (2021-2026) & (US$ Million) Table 71. North America China PD-L1 and PIK3CA Testing Revenue by Country (US$ Million) & (2027-2032) Table 72. Europe China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026) & (US$ Million) Table 73. Europe China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032) & (US$ Million) Table 74. Europe China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026) & (US$ Million) Table 75. Europe China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032) & (US$ Million) Table 76. Europe China PD-L1 and PIK3CA Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Europe China PD-L1 and PIK3CA Testing Revenue by Country (2021-2026) & (US$ Million) Table 78. Europe China PD-L1 and PIK3CA Testing Revenue by Country (US$ Million) & (2027-2032) Table 79. China China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026) & (US$ Million) Table 80. China China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032) & (US$ Million) Table 81. China China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026) & (US$ Million) Table 82. China China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032) & (US$ Million) Table 83. Asia China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026) & (US$ Million) Table 84. Asia China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032) & (US$ Million) Table 85. Asia China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026) & (US$ Million) Table 86. Asia China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia China PD-L1 and PIK3CA Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Asia China PD-L1 and PIK3CA Testing Revenue by Region (US$ Million) & (2021-2026) Table 89. Asia China PD-L1 and PIK3CA Testing Revenue by Region (US$ Million) & (2027-2032) Table 90. SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026) & (US$ Million) Table 91. SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032) & (US$ Million) Table 92. SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026) & (US$ Million) Table 93. SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032) & (US$ Million) Table 94. SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2021-2026) & (US$ Million) Table 96. SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (US$ Million) & (2027-2032) Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. China PD-L1 and PIK3CA Testing Image Figure 2. Global China PD-L1 and PIK3CA Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global China PD-L1 and PIK3CA Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. PD-L1 Testing Image Figure 5. PIK3CA Testing Image Figure 6. Global China PD-L1 and PIK3CA Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global China PD-L1 and PIK3CA Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Diagnostic Center Image Figure 10. Others Image Figure 11. Global China PD-L1 and PIK3CA Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global China PD-L1 and PIK3CA Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global China PD-L1 and PIK3CA Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global China PD-L1 and PIK3CA Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global China PD-L1 and PIK3CA Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global China PD-L1 and PIK3CA Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Type (2021-2032) Figure 19. Global China PD-L1 and PIK3CA Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global China PD-L1 and PIK3CA Testing Revenue Market Share by Application (2021-2032) Figure 22. North America China PD-L1 and PIK3CA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032) Figure 24. North America China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032) Figure 25. North America China PD-L1 and PIK3CA Testing Revenue Share by Country (2021-2032) Figure 26. United States China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe China PD-L1 and PIK3CA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032) Figure 31. Europe China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032) Figure 32. Europe China PD-L1 and PIK3CA Testing Revenue Share by Country (2021-2032) Figure 33. Germany China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China China PD-L1 and PIK3CA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032) Figure 43. China China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032) Figure 44. Asia China PD-L1 and PIK3CA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032) Figure 46. Asia China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032) Figure 47. Asia China PD-L1 and PIK3CA Testing Revenue Share by Region (2021-2032) Figure 48. Japan China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA China PD-L1 and PIK3CA Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA China PD-L1 and PIK3CA Testing Revenue Share by Country (2021-2032) Figure 58. Brazil China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt China PD-L1 and PIK3CA Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • PD-L1 Testing
  • PIK3CA Testing
Applications
  • Hospital
  • Diagnostic Center
  • Others
Companies covered
  • Agilent Technologies
  • EntroGen
  • QIAGEN
  • Amoy Diagnostics
  • Roche
  • ACCB Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 China PD-L1 and PIK3CA Testing Market by Type
  3. 1.2.1 Global China PD-L1 and PIK3CA Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PD-L1 Testing
  5. 1.2.3 PIK3CA Testing
  6. 1.3 China PD-L1 and PIK3CA Testing Market by Application
  7. 1.3.1 Global China PD-L1 and PIK3CA Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Diagnostic Center
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 China PD-L1 and PIK3CA Testing Market Dynamics
  1. 2.1 China PD-L1 and PIK3CA Testing Industry Trends
  2. 2.2 China PD-L1 and PIK3CA Testing Industry Drivers
  3. 2.3 China PD-L1 and PIK3CA Testing Industry Opportunities and Challenges
  4. 2.4 China PD-L1 and PIK3CA Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global China PD-L1 and PIK3CA Testing Market Perspective (2021-2032)
  2. 3.2 Global China PD-L1 and PIK3CA Testing Growth Trends by Region
  3. 3.2.1 Global China PD-L1 and PIK3CA Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global China PD-L1 and PIK3CA Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global China PD-L1 and PIK3CA Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global China PD-L1 and PIK3CA Testing Revenue by Players
  2. 4.1.1 Global China PD-L1 and PIK3CA Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global China PD-L1 and PIK3CA Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global China PD-L1 and PIK3CA Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global China PD-L1 and PIK3CA Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global China PD-L1 and PIK3CA Testing Key Players Headquarters & Area Served
  7. 4.4 Global China PD-L1 and PIK3CA Testing Players, Product Type & Application
  8. 4.5 Global China PD-L1 and PIK3CA Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global China PD-L1 and PIK3CA Testing Market CR5 and HHI
  11. 4.6.3 2025 China PD-L1 and PIK3CA Testing Tier 1, Tier 2, and Tier 3
5 China PD-L1 and PIK3CA Testing Market Size by Type
  1. 5.1 Global China PD-L1 and PIK3CA Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global China PD-L1 and PIK3CA Testing Revenue by Type (2021-2032)
  3. 5.3 Global China PD-L1 and PIK3CA Testing Revenue Market Share by Type (2021-2032)
6 China PD-L1 and PIK3CA Testing Market Size by Application
  1. 6.1 Global China PD-L1 and PIK3CA Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global China PD-L1 and PIK3CA Testing Revenue by Application (2021-2032)
  3. 6.3 Global China PD-L1 and PIK3CA Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Agilent Technologies
  2. 7.1.1 Agilent Technologies Company Information
  3. 7.1.2 Agilent Technologies Business Overview
  4. 7.1.3 Agilent Technologies China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Agilent Technologies China PD-L1 and PIK3CA Testing Product Portfolio
  6. 7.1.5 Agilent Technologies Recent Developments
  7. 7.2 EntroGen
  8. 7.2.1 EntroGen Company Information
  9. 7.2.2 EntroGen Business Overview
  10. 7.2.3 EntroGen China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 EntroGen China PD-L1 and PIK3CA Testing Product Portfolio
  12. 7.2.5 EntroGen Recent Developments
  13. 7.3 QIAGEN
  14. 7.3.1 QIAGEN Company Information
  15. 7.3.2 QIAGEN Business Overview
  16. 7.3.3 QIAGEN China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 QIAGEN China PD-L1 and PIK3CA Testing Product Portfolio
  18. 7.3.5 QIAGEN Recent Developments
  19. 7.4 Amoy Diagnostics
  20. 7.4.1 Amoy Diagnostics Company Information
  21. 7.4.2 Amoy Diagnostics Business Overview
  22. 7.4.3 Amoy Diagnostics China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Amoy Diagnostics China PD-L1 and PIK3CA Testing Product Portfolio
  24. 7.4.5 Amoy Diagnostics Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche China PD-L1 and PIK3CA Testing Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 ACCB Biotech
  32. 7.6.1 ACCB Biotech Company Information
  33. 7.6.2 ACCB Biotech Business Overview
  34. 7.6.3 ACCB Biotech China PD-L1 and PIK3CA Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ACCB Biotech China PD-L1 and PIK3CA Testing Product Portfolio
  36. 7.6.5 ACCB Biotech Recent Developments
8 North America
  1. 8.1 North America China PD-L1 and PIK3CA Testing Revenue (2021-2032)
  2. 8.2 North America China PD-L1 and PIK3CA Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032)
  5. 8.3 North America China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America China PD-L1 and PIK3CA Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032)
  9. 8.5 North America China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America China PD-L1 and PIK3CA Testing Revenue by Country
  11. 8.6.1 North America China PD-L1 and PIK3CA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America China PD-L1 and PIK3CA Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America China PD-L1 and PIK3CA Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe China PD-L1 and PIK3CA Testing Revenue (2021-2032)
  2. 9.2 Europe China PD-L1 and PIK3CA Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032)
  5. 9.3 Europe China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe China PD-L1 and PIK3CA Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032)
  9. 9.5 Europe China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe China PD-L1 and PIK3CA Testing Revenue by Country
  11. 9.6.1 Europe China PD-L1 and PIK3CA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe China PD-L1 and PIK3CA Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe China PD-L1 and PIK3CA Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China China PD-L1 and PIK3CA Testing Revenue (2021-2032)
  2. 10.2 China China PD-L1 and PIK3CA Testing Revenue by Type (2021-2032)
  3. 10.2.1 China China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026)
  4. 10.2.2 China China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032)
  5. 10.3 China China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032)
  6. 10.4 China China PD-L1 and PIK3CA Testing Revenue by Application (2021-2032)
  7. 10.4.1 China China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026)
  8. 10.4.2 China China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032)
  9. 10.5 China China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia China PD-L1 and PIK3CA Testing Revenue (2021-2032)
  2. 11.2 Asia China PD-L1 and PIK3CA Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032)
  5. 11.3 Asia China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia China PD-L1 and PIK3CA Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032)
  9. 11.5 Asia China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia China PD-L1 and PIK3CA Testing Revenue by Country
  11. 11.6.1 Asia China PD-L1 and PIK3CA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia China PD-L1 and PIK3CA Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia China PD-L1 and PIK3CA Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA China PD-L1 and PIK3CA Testing Revenue (2021-2032)
  2. 12.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA China PD-L1 and PIK3CA Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA China PD-L1 and PIK3CA Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country
  11. 12.6.1 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA China PD-L1 and PIK3CA Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst